awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35813229-7F8EFA28-48A9-40DD-9434-53108C3D0A7B
Q35813229-7F8EFA28-48A9-40DD-9434-53108C3D0A7B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35813229-7F8EFA28-48A9-40DD-9434-53108C3D0A7B
Bevacizumab as a second- or later-line of treatment for metastatic colorectal cancer.
P2860
Q35813229-7F8EFA28-48A9-40DD-9434-53108C3D0A7B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35813229-7F8EFA28-48A9-40DD-9434-53108C3D0A7B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9ed2cf693e3812ac518c0de7b74439dc0ed94801
P2860
FDA drug approval summary: bevacizumab (Avastin) plus Carboplatin and Paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer.